Rowan Stringer

1.6k citations

23 papers · 874 indexed · h-index 17

Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 9
- Drug-Induced Hepatotoxicity and Protection 2
Oncology
- Drug Transport and Resistance Mechanisms 8
Computational Theory and Mathematics top 5%
Sensory Systems top 10%
Pharmaceutical Science top 10%
Behavioral Neuroscience
- Stress Responses and Cortisol 2
Immunology
- IL-33, ST2, and ILC Pathways 2
- Psoriasis: Treatment and Pathogenesis 2
Pediatrics, Perinatology and Child Health
- Pharmacological Effects and Toxicity Studies 2
Biological Psychiatry
- Tryptophan and brain disorders 2

Co-authors: J. Brian Houston Bindi Sohal Paul Nicklin Peter Kilford Aleksandra Galetin Matthew J. Thomas John Westwick Christoph Walker
Cited by: Pharmacology Oncology Computational Theory and Mathematics
Journals: Journal of Medicinal Chemistry (5 papers)Drug Metabolism and Disposition (5 papers)Xenobiotica (2 papers)
Partner nations: Switzerland United Kingdom United States

In The Last Decade

Rowan Stringer

23 papers receiving 853 citations

Peers

Countries citing papers authored by Rowan Stringer

Since Specialization

Citations

This map shows the geographic impact of Rowan Stringer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rowan Stringer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rowan Stringer more than expected).

Fields of papers citing papers by Rowan Stringer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rowan Stringer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rowan Stringer. The network helps show where Rowan Stringer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Rowan Stringer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rowan Stringer Line = papers co-authored together Rowan Stringer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Predicting the Intravenous Pharmacokinetics of Covalent Drugs in Animals and Humans Journal of Medicinal Chemistry ·Rowan Stringer,Sung-soon Park	2024	1
2	Drug‐Drug Interaction Studies to Evaluate the Effect of Inhibition of UGT1A1 and CYP3A4 and Induction of CYP3A4 on the Pharmacokinetics of Tropifexor in Healthy Subjects Clinical Pharmacology in Drug Development ·Jin Chen,Rowan Stringer,Cagla Sevinc,Jessie Gu,Yiming Zhang,Mohammad Amin Zadenoori,William Prince,Ralph Woessner	2022	3
3	Discovery and Optimization of Novel SUCNR1 Inhibitors: Design of Zwitterionic Derivatives with a Salt Bridge for the Improvement of Oral Exposure Journal of Medicinal Chemistry ·Juraj Velcicky,Rainer Wilcken,Simona Cotesta,Philipp Janser,Achim Schlapbach,Trixie Wagner,Philippe Piéchon,Frédéric Villard,Rochdi Bouhelal,Fabian M. Piller,Stephanie Harlfinger,Rowan Stringer,Dominique Fehlmann,Klemens Kaupmann,Amanda Littlewood‐Evans,Matthias Haffke,Nina Gommermann	2020	24
4	Optimizing a Weakly Binding Fragment into a Potent RORγt Inverse Agonist with Efficacy in an in Vivo Inflammation Model Journal of Medicinal Chemistry ·David A. Carcache,Anna Vulpetti,Joerg Kallen,Henri Mattes,David Orain,Rowan Stringer,Eric Vangrevelinghe,Romain M. Wolf,Klemens Kaupmann,Johannes Ottl,Janet Dawson,Nigel G. Cooke,Klemens Hoegenauer,Andreas Billich,Juergen Wagner,Christine Guntermann,Samuel Hintermann	2018	18
5	Retinoic-acid-orphan-receptor-C inhibition suppresses Th17 cells and induces thymic aberrations JCI Insight ·Christine Guntermann,Alessandro Piaia,Andrea Danzi,Diethilde Theil,Tina Rubic-Schneider,Alberto Del Río-Espínola,Linda M. Dong,Andreas Billich,Klemens Kaupmann,Janet Dawson,Klemens Hoegenauer,David Orain,Samuel Hintermann,Rowan Stringer,Dhavalkumar D. Patel,Arno Doelemeyer,Mark Deurinck,Jens Schümann	2017	41
6	Application of Osmotic Pumps for Sustained Release of 1-Aminobenzotriazole and Inhibition of Cytochrome P450 Enzymes in Mice: Model Comparison with the Hepatic P450 Reductase Null Mouse Drug Metabolism and Disposition ·Rowan Stringer,Minqi Shao,Jonathan A. Rose,Sébastien Ronseaux	2016	3
7	Evaluation of the GastroPlus™ Advanced Compartmental and Transit (ACAT) Model in Early Discovery Pharmaceutical Research ·Nathalie Gobeau,Rowan Stringer,Stefan Buck,Tove Tuntland,Giulia Tamponi	2016	44
8	1-Aminobenzotriazole Modulates Oral Drug Pharmacokinetics through Cytochrome P450 Inhibition and Delay of Gastric Emptying in Rats Drug Metabolism and Disposition ·Rowan Stringer,Eckhard Weber,Bruno Tigani,程亚林,Stephen J. Medhurst,Bindi Sohal	2014	18
9	Preclinical metabolism and pharmacokinetics of NVS-CRF38, a potent and orally bioavailable corticotropin-releasing factor receptor 1 antagonist Xenobiotica ·Rowan Stringer,Eckhard Weber,Andrew J. Culshaw,E. Mayordomo Gonzales,Gareth Williams,Jonathan A. Rose,Bindi Sohal	2014	2
10	Application of a Deuterium Replacement Strategy to Modulate the Pharmacokinetics of 7-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-3-(4-methoxy-2-methylphenyl)-2,6-dimethylpyrazolo[5,1-b]oxazole, a Novel CRF1 Antagonist Drug Metabolism and Disposition ·Rowan Stringer,Gareth Williams,Franck Picard,Bindi Sohal,Olivier Kretz,E. Mayordomo Gonzales,Joel A. Krauser	2014	18
11	Discovery, Optimization, and Biological Evaluation of 5-(2-(Trifluoromethyl)phenyl)indazoles as a Novel Class of Transient Receptor Potential A1 (TRPA1) Antagonists Journal of Medicinal Chemistry ·Ezzeddine Chakroun,Thanakan Kitnithiprapha,Laura Vita,Paula Nogueira Machado Schffer,Olga Myriam Kurtz,Sally A. Beyer,Toyonori Yamauchi,R. I. Egbert,Rowan Stringer,Jianmin Lao,Matt Petrus,Ardem Patapoutian,Mark S. Nash,GLORIA E. BALAGTAS-BUROW,Moh Panesar,J. Martin Verkuyl,Andrew M. Schumacher,H. Michael Petrassi,David C. Tully	2014	41
12	Transient targeting of phosphoinositide 3-kinase acts as a roadblock in mast cells' route to allergy Journal of Allergy and Clinical Immunology ·V. O. Björk,Thomas Bohnacker,Romina Marone,Janet Dawson,Markus Rehberg,Rowan Stringer,Fritz Krombach,Christoph Burkhart,Emilio Hirsch,Gregory J. Hollingworth,Matthew J. Thomas,Matthias P. Wymann	2013	24
13	A Novel Murine Model of Severe Pulmonary Arterial Hypertension American Journal of Respiratory and Critical Care Medicine ·Loredana Ciuclan,Olivier Bonneau,Martin Hussey,Nicholas Duggan,Alan Holmes,Robert B. Good,Rowan Stringer,Peter Lloyd Jones,Nicholas W. Morrell,Gábor Járai,Christoph Walker,John Westwick,Matthew J. Thomas	2011	205
14	A physical properties based approach for the exploration of a 4-hydroxybenzothiazolone series of β2-adrenoceptor agonists as inhaled long-acting bronchodilators Bioorganic & Medicinal Chemistry Letters ·David T. Beattie,Michael Cullen,A Vikkee,Steven J. Charlton,Bernard Cuenoud,Robin A. Fairhurst,Peter Gedeck,Martin Gosling,Harmon Gallant,Darryl Jones,Christine A. Lewis,Clive McCarthy,Nobuyuki Tanaka,Rowan Stringer,Roger Taylor,陳富美	2010	19
15	Evaluation of Recombinant Cytochrome P450 Enzymes as an in Vitro System for Metabolic Clearance Predictions Drug Metabolism and Disposition ·Rowan Stringer,Claire Strain‐Damerell,Paul Nicklin,J. Brian Houston	2009	52
16	Prediction of Drug Clearance by Glucuronidation from in Vitro Data: Use of Combined Cytochrome P450 and UDP-Glucuronosyltransferase Cofactors in Alamethicin-Activated Human Liver Microsomes Drug Metabolism and Disposition ·Peter Kilford,Rowan Stringer,Bindi Sohal,J. Brian Houston,Aleksandra Galetin	2008	150
17	Reliability of human cryopreserved hepatocytes and liver microsomes asin vitrosystems to predict metabolic clearance Xenobiotica ·Rowan Stringer,Paul Nicklin,J. Brian Houston	2008	65
18	Wild-type adenoviruses from groups A–F evoke unique innate immune responses, of which HAd3 and SAd23 are partially complement dependent Gene Therapy ·M A Muglia,Anne Kiang,H.O. Wuester,Hao Jiang,Sergey S. Seregin,Jeannine M. Scott,Rowan Stringer,Youssef A. Kousa,Meng Hai-gui,Martin Frank,Andrea Amalfitano	2008	42
19	Hybrid (BDBB) interferon-α: preformulation studies International Journal of Pharmaceutics ·John Allen,David L. Bentley,Rowan Stringer,С. М. Барайшук	1999	3
20	Synthesis, processing, and secretion of the Marek's disease herpesvirus A antigen glycoprotein Journal of Virology ·Robert J. Isfort,Rowan Stringer,H J Kung,L F Velicer	1986	34

About Rowan Stringer

Rowan Stringer is a scholar working on Pharmacology, Biological Psychiatry, Behavioral Neuroscience, Oncology and Toxicology, having authored 23 papers that have together received 874 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (8 papers), Stress Responses and Cortisol (2 papers), IL-33, ST2, and ILC Pathways (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Pharmacological Effects and Toxicity Studies (2 papers), Psoriasis: Treatment and Pathogenesis (2 papers) and Tryptophan and brain disorders (2 papers). The work is most often cited by research in Pharmacology (267 citations), Oncology (216 citations), Computational Theory and Mathematics (99 citations), Sensory Systems (30 citations) and Pharmaceutical Science (36 citations). Rowan Stringer has collaborated with scholars based in Switzerland, United Kingdom and United States. Frequent co-authors include J. Brian Houston, Bindi Sohal, Paul Nicklin, Peter Kilford, Aleksandra Galetin, J. Brian Houston, Matthew J. Thomas, John Westwick, Christoph Walker and Loredana Ciuclan. Their work appears in journals such as Journal of Medicinal Chemistry, Drug Metabolism and Disposition, Xenobiotica, Pharmaceutical Research and ChemMedChem.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact